Case Report
In Acute IgA Nephropathy, Proteinuria and Creatinine Are in the Spot, but Podocyturia Operates in Silence: Any Place for Amiloride?
Table 1
Clinical, biochemical, and interventional data.
| Variables | Days | 0 | 1 | 2 | 3 | 4 | 15 | 30 | 365 | Interventions | Admission | Biopsy steroids | ā | Biopsy result | Hospital discharge | Amiloride | Valsartan | ā |
| Blood pressure (mmHg) | 110/70 | 124/76 | 120/70 | 120/72 | 110/76 | 126/72 | 116/78 | 110/66 | Serum creatinine | 3 | 3.1 | 2.6 | 2.2 | 1.6 | 1.2 | 0.7 | 0.9 | CKD-EPI (mL/min) | 29 | 28 | 34 | 42 | 62 | 88 | 138 | 124 | Podocytes/gram urinary creatinine (cells/g) | 166 | NP | NP | NP | NP | 110 | 0.8 | 0.7 | Proteinuria (g/day) | 1.89 | NP | NP | NP | 1.1 | 0.5 | 0.07 | 0.09 | Dysmorphic red blood (%) | 95 | NP | NP | NP | 89 | 40 | 15 | 20 | Serum potassium (mEq/L) | 4.9 | 4.8 | 4.3 | 4.1 | 3.8 | 3.7 | 4.1 | 4.3 |
|
|
NP, not performed.
|